Follow the HYPERA S/A stock price and the full directors' dealings record of the company, a listed equity based in Brazil. Shares are quoted on the BR market, under the supervision of CVM (Brazil). Operating in the Health Care sector, HYPERA S/A has recorded 830 reports. Market capitalisation: €15.1bn. The latest transaction was filed on 10 August 2026 (Compra à vista (Crédito)). All data is openly available.
830
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HYPERA S/A Buy (bullish), based on 15 analysts. Average price target: R$29.17.
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,906 of 28,958 companies
68.7
score / 100
Value
74
Quality
64
FCF yld12%
Earn yld8.0%
EV/EBITDA10.7x
ROE13%
Gross mgn59%
Net mgn16%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.